iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.245
-0.015 (-1.19%)
Sep 22, 2026, 12:50 PM EDT - Market open
iBio, Inc. Market Cap
iBio, Inc. has a market cap or net worth of $80.06 million as of September 22, 2026. Its market cap has increased by 374.10% in one year.
Market Cap
80.06M
Enterprise Value
-5.78M
1-Year Change
374.10%
Ranking
Category
Stock Price
$1.25
ChartMarket Cap Chart
Since August 19, 2008, iBio, Inc.'s market cap has increased from $14.01M to $80.06M, an increase of 471.37%. That is a compound annual growth rate of 10.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 80.06M | 84.47% |
| Dec 31, 2025 | 43.40M | 93.61% |
| Dec 31, 2024 | 22.42M | 716.05% |
| Dec 29, 2023 | 2.75M | -41.32% |
| Dec 30, 2022 | 4.68M | -96.09% |
| Dec 31, 2021 | 119.66M | -46.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telomir Pharmaceuticals | 85.28M |
| Connect Biopharma Holdings | 83.13M |
| NeOnc Technologies Holdings | 82.77M |
| Aldeyra Therapeutics | 81.44M |
| MAIA Biotechnology | 80.90M |
| Fortress Biotech | 80.38M |
| Gain Therapeutics | 80.30M |
| OS Therapies | 80.26M |